About MAP Pharmaceuticals

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
pharmaceuticals
Location
Location
US
Description
Information
MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX™ inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

MAP Pharmaceuticals Alternatives

Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals

Frequently Asked Questions about MAP Pharmaceuticals

What is MAP Pharmaceuticals email format?

The widely used MAP Pharmaceuticals email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.


What is MAP Pharmaceuticals customer service number?

To contact MAP Pharmaceuticals customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more